Cervical Intraepithelial Lesions: A Systematic Review
DOI:
https://doi.org/10.35381/s.v.v10i2.5081Palabras clave:
Epithelial cells, uterine cervix, cancer, (Source: DeCS).Resumen
Cervical cancer remains a major cause of morbidity and mortality among women worldwide, particularly in low- and middle-income countries. This study aimed to systematically synthesise published evidence on the reported prevalence ranges of cervical cytological abnormalities—atypical. A systematic literature review was conducted in accordance with PRISMA guidelines. Higher proportions of abnormal cytology were consistently reported in resource-constrained settings with limited organised screening programmes. Strengthening organised screening programmes, improving cytotechnologist training, and enhancing follow-up systems are essential to reduce variability and disease burden. Limitations include heterogeneity in study designs and reporting standards, as well as exclusion of non-accessible publications.
Descargas
Citas
Organización Mundial de la Salud. Estrategia mundial para la eliminación del cáncer cervicouterino | UICC. [citado 14 de diciembre de 2024]; Disponible en: https://n9.cl/t5pej
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 24 de abril de 2002;287(16):2114-9.
Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
Nayar R, Wilbur DC. The Pap Test and Bethesda 2014: “The reports of my demise have been greatly exaggerated.” (after a quotation from Mark Twain). Acta Cytol [Internet]. 19 de mayo de 2015 [citado 14 de diciembre de 2024];59(2):121-32. Disponible en: https://doi.org/10.1159/000381842
Yusheng Zhu, Sarah Feldman, Shuk On Annie Leung. Cervical Cancer Detection. 2023 [Internet]. 6 de marzo de 2023 [citado 14 de diciembre de 2024]; Disponible en: https://acortar.link/5kDeGc
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. abril de 2013;17(5 Suppl 1): S1-27.
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, et al. A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. eClinicalMedicine [Internet]. 1 de mayo de 2020 [citado 14 de diciembre de 2024];22. Disponible en: https://acortar.link/I6rxjk
Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol [Internet]. 1 de septiembre de 2011 [citado 14 de diciembre de 2024];12(9):880-90. Disponible en: https://acortar.link/R0ytCL
Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst. 3 de marzo de 2010;102(5):315-24.
Moher D, Liberati A, M. Tetzlaff J. (PDF) Moher D, Liberati A, Tetzlaff J, Altman DG, Group PPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097. ResearchGate [Internet]. 21 de noviembre de 2024 [citado 14 de diciembre de 2024]; Disponible en: https://acortar.link/Y5XSI
From a large referral hospital in Saudi Arabia using the revised 2001 Bethesda System [Internet]. [citado 15 de diciembre de 2024]. Disponible en: https://www.annsaudimed.net/doi/epdf/105144/0256-4947.2007.268
Ali-Risasi C, Verdonck K, Padalko E, Vanden Broeck D, Praet M. Prevalence and risk factors for cancer of the uterine cervix among women living in Kinshasa, the Democratic Republic of the Congo: a cross-sectional study. Infect Agent Cancer [Internet]. diciembre de 2015 [citado 15 de diciembre de 2024];10(1):1-11. Disponible en: https://acortar.link/KHdSch
Niyazee AAQA, Abedalrahman SK, Saleh LAM. Prevalence of Cytological Abnormality of Cervical Papanicolaou Smear. World Fam Med J Inc Middle East J Fam Med [Internet]. noviembre de 2019 [citado 15 de diciembre de 2024];99(6588):1-6. Disponible en: https://platform.almanhal.com/Details/Article/138352?lang=en
Bonvicino A, Huitron S, Fadare O. Papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion”. Cancer Cytopathol [Internet]. 2007 [citado 15 de diciembre de 2024];111(6):477-81. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.23121
Barcelos ACM, Michelin MA, Adad SJ, Murta EFC. Atypical Squamous Cells of Undetermined Significance: Bethesda Classification and Association with Human Papillomavirus. Infect Dis Obstet Gynecol [Internet]. 2011 [citado 15 de diciembre de 2024];2011(1):904674. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1155/2011/904674
Barron S, Li Z, Austin RM, Zhao C. Low-Grade Squamous Intraepithelial Lesion/Cannot Exclude High-Grade Squamous Intraepithelial Lesion (LSIL-H) Is a Unique Category of Cytologic Abnormality Associated with Distinctive HPV and Histopathologic CIN 2+ Detection Rates. Am J Clin Pathol [Internet]. 1 de febrero de 2014 [citado 15 de diciembre de 2024];141(2):239-46. Disponible en: https://doi.org/10.1309/AJCPM9X5RCZYEQJQ
Çetiner H, Kır G, Kaygusuz E, Sağlıcan Y, Kabaca C. Is the Low-Grade Squamous Intraepithelial Lesion/Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion Category Associated with Cervical Intraepithelial Neoplasia 2? Acta Cytol [Internet]. 1 de octubre de 2013 [citado 15 de diciembre de 2024];57(6):581-4. Disponible en: https://doi.org/10.1159/000353824
Bruno MT, Ferrara M, Fava V, Barrasso G, Panella MM. A prospective study of women with ASCUS or LSIL pap smears at baseline and HPV E6/E7 mRNA positive: a 3-year follow- up. Epidemiol Infect [Internet]. abril de 2018 [citado 15 de diciembre de 2024];146(5):612-8. Disponible en: https://acortar.link/y3Mp47
Dhaubhadel P, Vaidya A, Choudhary P. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid. JNMA J Nepal Med Assoc. 2008;47(170):71-6.
Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, et al. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. J Low Genit Tract Dis [Internet]. octubre de 2017 [citado 15 de diciembre de 2024];21(4):261. Disponible en https://acortar.link/oxM3dz
Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis [Internet]. diciembre de 2009 [citado 15 de diciembre de 2024];9(1):1-6. Disponible en: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-9-191
Fonseca FV, Cordeiro MVG, Pozza AC, Maestri CA. Cervical Intraepithelial Neoplasia: Analyzing the Disease Present Exclusively in the Endocervical Canal. Rev Bras Ginecol E Obstetrícia [Internet]. 11 de marzo de 2022 [citado 15 de diciembre de 2024]; 44(4):385-90. Disponible en: https://acortar.link/nQ0a16
Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. J Cytol [Internet]. marzo de 2012 [citado 15 de diciembre de 2024];29(1):45. Disponible en: https://acortar.link/zdW6dv
Hirachand S, Bajracharya J, Pradhanang S, Lama S. Detection of abnormal cervical cytology in papanicolaou smears in a tertiary care center. JNMA J Nepal Med Assoc. 2013;52(191):462-5.
Hong SR, Kim BM, Kim HS, Chun YK, Kim HS. Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear. J Pathol Transl Med [Internet]. [citado 15 de diciembre de 2024];44(5):528-35. Disponible en: https://acortar.link/qy09Ba
AleksioskaPapestiev I, Chibisheva V, Micevska M, Dimitrov G. Prevalence of Specific Types of Human Papilloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women. Med Arch [Internet]. 2018 [citado 15 de diciembre de 2024];72(1):26. Disponible en: https://ejmanager.com/fulltextpdf.php?mno=288441
De Brot L, Pellegrini B, Moretti ST, Carraro DM, Soares FA, Rocha RM, et al. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix. Cancer Cytopathol [Internet]. 2017 [citado 15 de diciembre de 2024];125(2):138-43. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/cncy.21789
Poomtavorn Y, Suwannarurk K, Thaweekul Y, Maireang K. Diagnostic Value of Endocervical Curettage for Detecting Dysplastic Lesions in Women with Atypical Squamous Cells of Undetermined Significance (ASC-US) and Low Grade Squamous Intraepithelial Lesion (LSIL) Papanicolaou Smears. Asian Pac J Cancer Prev [Internet]. 2014 [citado 15 de diciembre de 2024];15(8):3461-4. Disponible en: https://koreascience.or.kr/article/JAKO201418342937023.page
Saad RS, Dabbs DJ, Kordunsky L, Kanbour-Shakir A, Silverman JF, Liu Y, et al. Clinical Significance of Cytologic Diagnosis of Atypical Squamous Cells, Cannot Exclude High Grade, in Perimenopausal and Postmenopausal Women. Am J Clin Pathol [Internet]. 1 de septiembre de 2006 [citado 15 de diciembre de 2024];126(3):381-8. Disponible en: https://doi.org/10.1309/XVB01JQYQNM7MJXU
Ricaurte-Guerrero O. Prevalencia de lesión escamosa intraepitelial (LEI) y malignidad para las atipias escamosas de significado indeterminado (ASC-US), en población perteneciente a una aseguradora pública en Colombia, 2004 - 2005. Rev Colomb Obstet Ginecol [Internet]. 30 de junio de 2008 [citado 15 de diciembre de 2024];59(2):124-30. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/418
Muitta E, Were T, Nyamache AK, Muhoho N. Atypical cervical cytomorphologic predictors: a descriptive study of pre-cervical cancer patients of low education in Kenya. Pan Afr Med J [Internet]. 18 de junio de 2019 [citado 15 de diciembre de 2024];33(124). Disponible en: https://www.panafrican-med-journal.com//content/article/33/124/full
Cohen D, Austin RM, Gilbert C, Freij R, Zhao C. Follow-up Outcomes in a Large Cohort of Patients with Human Papillomavirus–Negative ASC-H Cervical Screening Test Results. Am J Clin Pathol [Internet]. 1 de octubre de 2012 [citado 15 de diciembre de 2024];138(4):517-23. Disponible en: https://doi.org/10.1309/AJCPYK60BZRNNAHQ
Sherman ME, Solomon D, Schiffman M, for the ALTS Group. Qualification of ASCUS: A Comparison of Equivocal LSIL and Equivocal HSIL Cervical Cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol [Internet]. 1 de septiembre de 2001 [citado 15 de diciembre de 2024];116(3):386-94. Disponible en: https://doi.org/10.1309/JM3V-U4HP-W8HJ-68XV
Shiramba T, Bigirimana V, Imuragire J, Kalinganire N. CERVICAL SQUAMOUS INTRAEPITHERIAL LESIONS AT KING FAISAL HOSPITAL: A SYSTEMATIC REVIEW: APRIL 2009 - APRIL 201. 2012;
Syler LB, Stobaugh CL, Foulis PR, Carlton GT, DeLand LA, Borkowski AA, et al. Cervical Cancer Screening in South Florida Veteran Population, 2014 to 2020: Cytology and High-Risk Human Papillomavirus Correlation and Epidemiology. Cureus [Internet]. 17 de Agosto de 2021 [citado 15 de diciembre de 2024];13. Disponible en: https://acortar.link/qcmtQV
Khan KA, Smith DA, Thrall MJ. Only a Small Fraction of High-Grade Cervical Lesions Are Discovered After an Interpretation of Atypical Squamous Cells of Undetermined Significance When Using Imager-Assisted, Liquid-Based Papanicolaou Tests and the Bethesda 2001 System. Arch Pathol Lab Med [Internet]. 20 de septiembre de 2012 [citado 15 de diciembre de 2024];137(7):936-41. Disponible en: https://doi.org/10.5858/arpa.2012-0358
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2026 Adán Joél Villanueva-Sosa
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
